跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,880 条关于
“Alzheimer's psychosis”
全部
6,880
临床试验
4,999
药物
116
机构
18
资讯
1,747
8个月前
Acadia Pharmaceuticals Projects $1.7 Billion Revenue by 2028, Advances Alzheimer's Psychosis Pipeline
9个月前
Bristol Myers Squibb Delays Cobenfy Alzheimer's Psychosis Trial Results to 2026 Following Site Irregularities
去年
AI-Designed Drug for Alzheimer's Psychosis Enters Clinical Trials
8个月前
MapLight Therapeutics Receives FDA Fast Track Designation for Alzheimer's Disease Psychosis Treatment
2个月前
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
2年前
Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis
去年
Acadia Pharmaceuticals Unveils $12 Billion Pipeline Strategy at Inaugural R&D Day
去年
Alzheimer's Disease Pipeline Shows Promise with 120+ Therapies in Development
上个月
Acadia Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
去年
AbbVie's Emraclidine Fails Phase 2 Schizophrenia Trial, Boosting Bristol Myers Squibb's Cobenfy
第 1 页,共 175 页
上一页
下一页